Sector |
|
Compare with Sector peers |
Industry |
|
Compare with Industry peers |
Website | http://www.arveelabs.com | |
Market Cap | 209.60 Cr. | |
Enterprise Value(EV) | 203.15 Cr. | 2023-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 1.48 | Trailing Twelve Months Ending 2023-09 |
Price-Earning Ratio (PE) | 128.83 | Trailing Twelve Months Ending 2023-09 |
Industry PE | 37.98 | Trailing Twelve Months Ending 2023-09 |
Book Value / Share | 26.10 | Trailing Twelve Months Ending 2023-09 |
Price to Book Value | 7.29 | Calculated using Price: 190.20 |
Dividend Yield | 0.00 | Period Ending 2023-03 |
No. of Shares Subscribed | 1.10 Cr. | 11,020,000 Shares |
FaceValue | 10 | |
About Arvee Laboratories (India) Ltd. | ||
The company is mainly engaged in manufacturing of Polymer Modifiers, Contrast Media Intermediates and Drug Intermediates. The company caters to the demand of both domestic as well as international markets. Arvee Labs bought land, building and machineries from Skylink Chemicals who was engaged in manufacturing of specialty chemicals. Currently, it is negotiating with IDBI Bank to take over the business of Skylead Chemicals. |
1 Day |
|
+20.00% |
1 Week |
|
+40.94% |
1 Month |
|
+59.03% |
3 Month |
|
+68.84% |
6 Month |
|
+82.18% |
1 Year |
|
+49.23% |
2 Year |
|
+130.83% |
5 Year |
|
+638.64% |
10 Year |
|
9 years | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | 2023-03 | |
Return on Equity (%) | -73.58 | 9.24 | 45.41 | 12.01 | 14.97 | 13.17 | 13.38 | 11.36 | 15.84 | |
Return on Capital Employed (%) | 7.51 | 14.39 | 15.19 | 17.69 | 14.10 | 15.79 | 15.99 | 13.33 | 23.35 | |
Return on Assets (%) | -7.58 | 0.61 | 4.38 | 2.73 | 5.57 | 6.50 | 7.17 | 6.46 | 10.65 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
Shh. Funds | 1 | 3 | 4 | 14 | 16 | 19 | 21 | 24 | 28 | 29 | |
Non Curr. Liab. | 16 | 18 | 17 | 9 | 4 | 2 | 1 | 1 | 2 | 2 | |
Curr. Liab. | 9 | 14 | 15 | 21 | 17 | 12 | 18 | 14 | 9 | 5 | |
Minority Int. | |||||||||||
Equity & Liab. | 26 | 35 | 36 | 44 | 37 | 34 | 41 | 39 | 39 | 35 | |
Non Curr. Assets | 14 | 18 | 17 | 17 | 16 | 16 | 15 | 15 | 17 | 15 | |
Curr. Assets | 12 | 18 | 19 | 27 | 21 | 18 | 26 | 24 | 22 | 20 | |
Misc. Exp. not W/O | 0 | 0 | 0 | 0 | 0 | ||||||
Total Assets | 26 | 35 | 36 | 44 | 37 | 34 | 41 | 39 | 39 | 35 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09 Rs. Cr. TTM |
Net Sales | 13 | 27 | 34 | 48 | 55 | 45 | 47 | 40 | 61 | 45 | |
Other Income | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 0 | |
Total Income | 13 | 27 | 35 | 48 | 55 | 46 | 48 | 41 | 63 | 46 | |
Total Expenditure | -11 | -22 | -29 | -41 | -49 | -39 | -41 | -35 | -54 | -41 | |
PBIDT | 2 | 5 | 6 | 7 | 7 | 6 | 7 | 6 | 9 | 5 | |
Interest | -2 | -3 | -3 | -3 | -2 | -1 | -1 | 0 | 0 | 0 | |
Depreciation | -1 | -1 | -2 | -2 | -2 | -2 | -2 | -2 | -2 | -2 | |
Taxation | -1 | 0 | 1 | -1 | 0 | -1 | -1 | -1 | -2 | -1 | |
Exceptional Items | |||||||||||
PAT | -2 | 0 | 2 | 1 | 2 | 2 | 3 | 3 | 4 | 2 | |
Adjusted EPS | -3 | 0 | 2 | 1 | 2 | 2 | 2 | 2 | 4 | 1 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
Cash Fr. Operatn. | 0 | 9 | 6 | 4 | 6 | 9 | 10 | 2 | 4 | 3 | |
Cash Fr. Inv. | -6 | -6 | -5 | -1 | -1 | -3 | -3 | -1 | 0 | -1 | |
Cash Fr. Finan. | 7 | -2 | -1 | -3 | -4 | -5 | -10 | 5 | -6 | -2 | |
Net Change | 0 | 1 | 0 | 0 | 1 | 2 | -3 | 6 | -2 | -1 | |
Cash & Cash Eqvt | 0 | 1 | 1 | 1 | 2 | 4 | 1 | 7 | 5 | 1 |
Mon, 11 Dec 2023
Price movement
|
|
Mon, 11 Dec 2023
Price movement
|
|
Wed, 08 Nov 2023
Financial Result Updates
|
Mon, 11 Dec 2023 |
|
|
|
|
|